Group 1 - The event held in Taicang City focused on promoting the standardized application of nuclear technology in disease diagnosis, targeted therapy, and efficacy evaluation, aiming for equitable access to quality nuclear medical resources [1] - The "One County, One Department" strategic research platform for nuclear medicine aims to provide comprehensive solutions for the establishment of nuclear medicine departments in grassroots hospitals, supporting the implementation of the "One County, One Department" strategy [1] - The AI innovation platform for nuclear medicine research wards will enhance clinical research quality and efficiency through AI-enabled solutions for clinical trials, radiomics research, and patient follow-up management [1] Group 2 - The establishment of the Kunrun Shengyan (Suzhou) Technology Co., Ltd. in Shaxi is expected to inject strong momentum into the growth of the local biopharmaceutical industry, leveraging its comprehensive core competencies across software, intelligent hardware, algorithms, and data [2] - Kunrun Shengyan is recognized as a major scientific research achievement transformation enterprise under the national "863" program, filling multiple technological gaps in the industry [2]